Proxicromil

Proxicromil
Names
Preferred IUPAC name
5-Hydroxy-4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylic acid
Other names
Proxicromilum
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
UNII
  • InChI=1S/C17H18O5/c1-2-5-11-9-6-3-4-7-10(9)15(19)14-12(18)8-13(17(20)21)22-16(11)14/h8,19H,2-7H2,1H3,(H,20,21)
    Key: VFFTVZUIDYJUQS-UHFFFAOYSA-N
  • CCCC1=C2C(=C(C3=C1CCCC3)O)C(=O)C=C(O2)C(=O)O
Properties
C17H18O5
Molar mass 302.326 g·mol−1
Melting point 219 °C (426 °F; 492 K)
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
May cause cancer
GHS labelling:
Danger
H350
P301+P312+P330, P308+P313
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Proxicromil is a detergent-like, lipophilic oral medication developed in the late 1970s that was not admitted on the market because of its possible carcinogenic effects. It suppresses allergic reactions by binding to FcεRI receptor in mast cells, thereby inhibiting production of histamines. It is absorbed through the gastrointestinal tract, and has been proven hepatotoxic for dogs as a result of its accumulation in biliary canaliculi.